Insight in the prediction of chemotherapy-induced nausea
- 23 August 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 18 (7), 869-876
- https://doi.org/10.1007/s00520-009-0723-2
Abstract
Purpose To identify risk factors for chemotherapy-related nausea. Methods We examined risk factors for nausea in 1,696 patients from three multicenter studies conducted from 1998 to 2004. All patients were beginning a chemotherapy regimen containing cisplatin, carboplatin, or doxorubicin. Nausea was assessed on a 1–7 scale four times a day for 4 days by diary. Results First, average nausea for breast cancer patients receiving doxorubicin (mean = 2.31) was significantly greater than for other patients receiving doxorubicin (mean = 1.82), patients receiving cisplatin (mean = 1.88), and patients receiving carboplatin (mean = 1.45), Ps < 0.01. Second, mean nausea decreased steadily with age, P < 0.0001. Third, patients rating themselves more susceptible to nausea had significantly more nausea (adjusted mean = 2.51) than patients rating themselves less susceptible (adjusted mean = 1.92) and were 2.8 times more likely to experience severe nausea, Ps < 0.0001. Fourth, expected nausea was a significant predictor of average nausea, P = 0.034, but not severe nausea, P = 0.31. Last, no evidence that gender is a significant predictor of nausea in 299 patients with gender neutral cancers, P = 0.35. Conclusions Specific patient characteristics, especially younger age and perceived susceptibility to nausea, can help clinicians in the early identification of patients who are more susceptible to treatment-related nausea.Keywords
This publication has 27 references indexed in Scilit:
- How do patient expectancies, quality of life, and postchemotherapy nausea interrelate?Cancer, 2008
- Effect of a Nausea Expectancy Manipulation on Chemotherapy-Induced Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program StudyJournal of Pain and Symptom Management, 2008
- Guidelines for Antiemetic Treatment of Chemotherapy-Induced Nausea and Vomiting: Past, Present, and Future RecommendationsThe Oncologist, 2007
- Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment responseSupportive Care in Cancer, 2006
- Patient expectation is a strong predictor of severe nausea after chemotherapyCancer, 2004
- Relationships between patients' pre-treatment expectations of toxicities and post chemotherapy experiencesPsycho‐Oncology, 2004
- The Efficacy of Acupressure and Acustimulation Wrist Bands for the Relief of Chemotherapy-Induced Nausea and Vomiting: A University of Rochester Cancer Center Community Clinical Oncology Program Multicenter StudyJournal of Pain and Symptom Management, 2003
- Effect of postchemotherapy nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 1997
- Etiology and treatment of the psychological side effects associated with cancer chemotherapy: A critical review and discussion.Psychological Bulletin, 1988
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981